Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cartesian Therapeutics, Inc. - Common Stock (NQ:RNAC)

10.34 -0.25 (-2.36%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 124,896
Open 10.64
Bid (Size) 10.06 (1,500)
Ask (Size) 11.19 (1,000)
Prev. Close 10.59
Today's Range 10.26 - 10.84
52wk Range 5.600 - 15.57
Shares Outstanding 115,079,292
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Cartesian Pauses Lupus And Multiple Myeloma Studies As It Shifts Development Focus ↗
Cartesian Therapeutics shared initial data from Phase 2 trial of Descartes-08, showing potential for treating systemic lupus erythematosus. 
Via Benzinga

Performance

YTD
+53.0%
+53.0%
1 Month
+76.5%
+76.5%
3 Month
+65.7%
+65.7%
6 Month
+49.6%
+49.6%
1 Year
-4.0%
-4.0%

More News

Read More
News headline image
Nvidia To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
Cartesian (RNAC) Q2 Revenue Drops 99% ↗
Via The Motley Fool
News headline image
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate ↗
Via Benzinga
News headline image
With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? ↗
Via Benzinga
News headline image
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert ↗
Via Benzinga
Topics Government World Trade
News headline image
Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Cartesian Therapeutics Reports Strong 12-Month Data For Lead Cell Therapy In Myasthenia Gravis Patients ↗
Via Benzinga
News headline image
Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Argenx Stock Surges As Amgen Struggles To Take On 'The King' In Autoimmune Diseases ↗
Via Investor's Business Daily
News headline image
RNAC Stock Earnings: Cartesian Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗
Via InvestorPlace
News headline image
Why NIO Shares Are Trading Lower By Over 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Via Benzinga
News headline image
Cartesian Therapeutics Plummets On 'Watershed Moment' For CAR-T Drugs ↗
Via Investor's Business Daily
News headline image
Cartesian's Autoimmune Disorder Candidate Hits Primary Goal In Mid-Stage Study, Announces Equity Raise Of $130M ↗
Via Benzinga
News headline image
RNAC Stock Earnings: Cartesian Therapeutics Misses EPS, Beats Revenue for Q1 2024 ↗
Via InvestorPlace
News headline image
Cartesian Therapeutics Announces New Employment Inducement Grants
From Cartesian Therapeutics, Inc.
Via Business Wire
News headline image
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Via Benzinga
News headline image
HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting
From Cartesian Therapeutics, Inc.
Via Business Wire
News headline image
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Cartesian Therapeutics' Rare Disease Candidate Shows Long Lasting Benefit Over Argenx's Vyvgart, Analyst Initiates With Buy ↗
Via Benzinga

Frequently Asked Questions

Is Cartesian Therapeutics, Inc. - Common Stock publicly traded?
Yes, Cartesian Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Cartesian Therapeutics, Inc. - Common Stock trade on?
Cartesian Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cartesian Therapeutics, Inc. - Common Stock?
The ticker symbol for Cartesian Therapeutics, Inc. - Common Stock is RNAC on the Nasdaq Stock Market
What is the current price of Cartesian Therapeutics, Inc. - Common Stock?
The current price of Cartesian Therapeutics, Inc. - Common Stock is 10.34
When was Cartesian Therapeutics, Inc. - Common Stock last traded?
The last trade of Cartesian Therapeutics, Inc. - Common Stock was at 07/06/26 04:00 PM ET
What is the market capitalization of Cartesian Therapeutics, Inc. - Common Stock?
The market capitalization of Cartesian Therapeutics, Inc. - Common Stock is 1.19B
How many shares of Cartesian Therapeutics, Inc. - Common Stock are outstanding?
Cartesian Therapeutics, Inc. - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.